C reactive protein testing in general practice safely reduces antibiotic use for flare-ups of COPD.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31888868.
- Also identified by DOI 10.1136/bmj.l5991.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The studyButler CC, Gillespie D, White P, et al. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. <i>N Engl J Med</i> 2019;381:111-20.This research was funded by the NIHR Technology Assessment Programme (project number 12/33/12). The testing machines used in the study were loaned to researchers by the manufacturer, who also provided training on their use. The manufacturer had no other role in any part of the trial.To read the full NIHR Signal, go to https://discover.dc.nihr.ac.uk/content/signal-000820/crp-testing-safely-reduces-antibiotic-use-for-copd-flare-ups.
Medical subject headings
- General Practice
- Pulmonary Disease, Chronic Obstructive